Publication Venue For
Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy.
Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.
Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma.
Prostate cancer management choices in patients undergoing multiparametric magnetic resonance imaging/ultrasound fusion biopsy compared to systematic biopsy.
Obesity as defined by waist circumference but not body mass index is associated with higher renal mass complexity.
Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer.
Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?.
Current management of paratesticular rhabdomyosarcoma.
Contemporary role of advanced imaging for bladder cancer staging.
Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy.
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes.
Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.
Pathological characteristics and radiographic correlates of complex renal cysts.
Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses.
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.
Minimal changes in the systemic immune response after nephrectomy of localized renal masses.
PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation.
Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: A preliminary analysis.
Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: Implications for novel intraoperative PSMA-based fluorescent imaging techniques.
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: Results from CaPSURE™.
PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinoma.
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Rubin, MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer, MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM, Department of Pathology, Brigham and Women's Hospital, Boston, MA..
Continuing trends in pathological stage migration in radical prostatectomy specimens.